Abstract:Modern drug design aims to discover novel lead compounds with attractable chemical profiles to enable further exploration of the intersection of chemical space and biological space. Identification of small molecules with good ligand efficiency, high activity, and selectivity is crucial toward developing effective and safe drugs. However, the intersection is one of the most challenging tasks in the pharmaceutical industry, as chemical space is almost infinity and continuous, whereas the biological space is very limited and discrete. This bottleneck potentially limits the discovery of molecules with desirable properties for lead optimization. Herein, we present a new direction leveraging posttranslational modification (PTM) protein isoforms target space to inspire drug design termed as "Post-translational Modification Inspired Drug Design (PTMI-DD)." PTMI-DD aims to extend the intersections of chemical space and biological space. We further rationalized and highlighted the importance of PTM protein isoforms and their roles in various diseases and biological functions. We then laid out a few directions to elaborate the PTMI-DD in drug design including discovering covalent binding inhibitors mimicking PTMs, targeting PTM protein isoforms with distinctive binding sites from that of wild-type counterpart, targeting protein-protein interactions involving PTMs, and hijacking protein degeneration by ubiquitination for PTM protein isoforms. These directions will lead to a significant expansion of the biological space and/or increase the tractability of compounds, primarily due to precisely targeting PTM protein isoforms or complexes which are highly relevant to biological functions. Importantly, this new avenue will further enrich the personalized treatment opportunity through precision medicine targeting PTM isoforms.

Proximity-Based Modalities for Biology and Medicine

Chemically induced proximity in biology and medicine

Synthetic modification of protein surfaces to mediate induced-proximity pharmacology

Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions

Bifunctional modalities for repurposing protein function

Mutual leveraging of proximity effects and click chemistry in chemical biology

Molecular Glues & Bifunctional Compounds: Therapeutic Modalities Based on Induced Proximity

Molecular Eye: A System for Precise Diagnosis and Treatment of Major Clinical Diseases Based on Molecular Probe Technology

Targeted Protein Posttranslational Modifications by Chemically Induced Proximity for Cancer Therapy

Drug design targeting active posttranslational modification protein isoforms

Small Bioactive Molecules Designed to Be Probes As Baits "fishing Out" Cellular Targets: Finding the Fish in the Proteome Sea

A chemical magnet: Approaches to guide precise protein localization

Leveraging Covalency to Stabilize Ternary Complex Formation For Cell-Cell "Induced Proximity"

Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes.

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives

Expanding the Horizons of Targeted Protein Degradation: A Non-Small Molecule Perspective

Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics

Target Bioconjugation of Protein Through Chemical, Molecular Dynamics, and Artificial Intelligence Approaches

Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors

Small-Molecule Modulation of Protein Lipidation: from Chemical Probes to Therapeutics.

Proximitomics by Reactive Species